Identification and hit-to-lead exploration of a novel series of histamine H4 receptor inverse agonists

Bioorg Med Chem Lett. 2010 Apr 15;20(8):2516-9. doi: 10.1016/j.bmcl.2010.02.097. Epub 2010 Mar 3.

Abstract

The identification and hit-to-lead exploration of a novel, potent and selective series of histamine H(4) receptor inverse agonists is described. The initial hit, 3A (IC(50) 19 nM) was identified by means of a ligand-based virtual screening approach. Subsequent medicinal chemistry exploration yielded 18I which possessed increased potency (R-enantiomer IC(50) 1 nM) as well as enhanced microsomal stability.

MeSH terms

  • Animals
  • Biological Availability
  • Drug Discovery
  • Histamine Antagonists / chemistry
  • Histamine Antagonists / pharmacokinetics
  • Histamine Antagonists / pharmacology*
  • Inhibitory Concentration 50
  • Macaca fascicularis
  • Rats
  • Receptors, G-Protein-Coupled / antagonists & inhibitors*
  • Receptors, Histamine
  • Receptors, Histamine H4
  • Stereoisomerism

Substances

  • Histamine Antagonists
  • Hrh4 protein, rat
  • Receptors, G-Protein-Coupled
  • Receptors, Histamine
  • Receptors, Histamine H4